You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Quadrivalent inactivated influenza vaccine (IIV).

Showing 1 - 25 of 9,134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Influenza (Healthy Volunteers) Trial in Ansan-si, Seoul (Quadrivalent Recombinant Influenza Vaccine (RIV4), Quadrivalent

Active, not recruiting
  • Influenza (Healthy Volunteers)
  • Quadrivalent Recombinant Influenza Vaccine (RIV4)
  • Quadrivalent inactivated influenza vaccine (IIV4)
  • Ansan-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Jul 1, 2022

Safety, Adverse Event Following Immunisation, Birth Outcomes Trial in Boston, Durham, Cincinnati (Quadrivalent Recombinant

Completed
Has Results
  • Safety
  • +2 more
  • Quadrivalent Recombinant Influenza Vaccine
  • Quadrivalent Inactivated Influenza Vaccine
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults

Recruiting
  • Influenza
  • +2 more
  • Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
  • High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Sep 1, 2023

Pain, Quality of Life, Injection Site Reaction Trial in Baltimore, Durham, Cincinnati (mRNA COVID-19, IIV4, Placebo)

Suspended
  • Pain
  • +3 more
  • mRNA COVID-19
  • +2 more
  • Baltimore, Maryland
  • +2 more
Jun 21, 2022

Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)

Active, not recruiting
  • Influenza
  • +3 more
  • Fluzone® quadrivalent
  • +5 more
  • Stanford, California
    Stanford LPCH Vaccine Program
Dec 12, 2022

Influenza Trial in Oakland (Flublok Quadrivalent influenza vaccine RIV4, Standard-dose quadrivalent inactivated influenza

Completed
  • Influenza
  • Flublok Quadrivalent influenza vaccine RIV4
  • Standard-dose quadrivalent inactivated influenza vaccine SD-IIV4
  • Oakland, California
    Kaiser Permanente Northern California
May 23, 2022

Influenza, Human, Pneumonia, Pneumococcal Trial in Quanzhou, Qingzhen, Qidong (IIV4 and PPV23, IIV4, PPV23)

Completed
  • Influenza, Human
  • Pneumonia, Pneumococcal
  • IIV4 and PPV23
  • +2 more
  • Quanzhou, Fujian, China
  • +3 more
Aug 1, 2022

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser

Active, not recruiting
  • Influenza
  • +5 more
  • Flublok Quadrivalent
  • Standard Dose Inactivated Influenza Vaccine (SD-IIV)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Feb 14, 2022

Influenza Trial in Stanford (Quadrivalent inactivated influenza vaccine (IIV))

Recruiting
  • Influenza
  • Quadrivalent inactivated influenza vaccine (IIV)
  • Stanford, California
    Stanford University School of Medicine
Mar 12, 2021

Influenza, Human, Pneumonia, Pneumococcal, Covid19 Trial in Chengdu, Shanghai, Taiyuan (COVAX+IIV4; COVAX+PPV23, COVAX only (1st

Completed
  • Influenza, Human
  • +2 more
  • COVAX+IIV4; COVAX+PPV23
  • +2 more
  • Chengdu, China
  • +2 more
Oct 12, 2021

Influenza, Human, Pneumonia, Pneumococcal, COVID-19 Pneumonia Trial in Guangzhou, Zhengzhou, Wuhan (COVAX+PPV23;COVAX+IIV4,

Active, not recruiting
  • Influenza, Human
  • +2 more
  • COVAX+PPV23;COVAX+IIV4
  • +2 more
  • Guangzhou, Guangdong, China
  • +2 more
Oct 5, 2021

Hemolysis, COVID-19 Trial in Changsha, Chengdu, Guiyang (coadministration, COVID-19 vaccine, IIV4+PPV23)

Not yet recruiting
  • Hemolysis
  • COVID-19
  • coadministration
  • +2 more
  • Changsha, China
  • +2 more
Aug 2, 2022

Influenza, Human Trial (Fluzone Quadrivalent, Flublok Quadrivalent)

Not yet recruiting
  • Influenza, Human
  • Fluzone Quadrivalent
  • Flublok Quadrivalent
  • (no location specified)
Aug 22, 2022

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated

Not yet recruiting
  • Immunization; Infection
  • +2 more
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jul 11, 2023

Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated

Not yet recruiting
  • Influenza
  • OVX836 480µg
  • +3 more
  • Raymond Terrace, Brisbane, Australia
    Mater Misericordiae University Hospital
Feb 9, 2023

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (High Dose Quadrivalent Inactivated Influenza

Recruiting
  • Immunization; Infection
  • +3 more
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt Univeristy Medical Center
May 27, 2022

Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

Not yet recruiting
  • Influenza, Human
  • Quadrivalent Influenza Vaccine (split virion, inactivated)
  • +2 more
  • (no location specified)
Mar 9, 2023

Influenza Trial in Brookvale (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo)

Completed
  • Influenza
  • OVX836 480µg
  • +2 more
  • Brookvale, New South Wales, Australia
    Northern Beaches Clinical Research
Dec 15, 2022

Quadrivalent Influenza Vaccine Immunization Schedule for

Completed
  • GCP
  • Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
  • Jinan, Shandong, China
    Kou Zengqiang
Oct 17, 2023

Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in

Suspended
  • Influenza Vaccine Effectiveness
    • Gainesville, Florida
    • +11 more
    Jan 13, 2023

    Influenza Immunization Trial (Recombinant influenza vaccine (RIV4) season/2022-2023/NH, Quadrivalent influenza vaccine (IIV4)

    Not yet recruiting
    • Influenza Immunization
    • Recombinant influenza vaccine (RIV4) season/2022-2023/NH
    • Quadrivalent influenza vaccine (IIV4) season/2022-2023/NH
    • (no location specified)
    Aug 23, 2022

    Influenza, Human Trial in United States (Experimental: IIV-A Investigational IIV-A will be administered as a single dose

    Not yet recruiting
    • Influenza, Human
    • Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1
    • +3 more
    • Tempe, Arizona
    • +44 more
    Aug 16, 2022

    Seasonal Influenza Trial in Zhumadian (Quadrivalent Influenza Vaccine (Split Virion), inactivated)

    Not yet recruiting
    • Seasonal Influenza
    • Quadrivalent Influenza Vaccine (Split Virion), inactivated
    • Zhumadian, Guizhou, China
      Yuping Dong Autonomous County Center for Disease Control and Pre
    Aug 21, 2022

    Influenza, Human Trial in United States (Investigational aIIV4c, IIV4c type 1, aIIV4)

    Completed
    • Influenza
    • Human
    • Investigational aIIV4c
    • +3 more
    • Mobile, Alabama
    • +20 more
    Mar 15, 2022

    Influenza Trial in Iowa City (DCVC H1 HA mRNA vaccine, Quadrivalent Recombinant Seasonal Influenza Vaccine, Sodium Chloride,

    Not yet recruiting
    • Influenza
    • DCVC H1 HA mRNA vaccine
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics - Department of Internal
    Jul 6, 2023